Hyperemesis gravidarum, severe nausea and vomiting of pregnancy, appears to be influenced at least in part by genetics, according to study findings.
Hyperemesis gravidarum (HG), severe nausea and vomiting of pregnancy, appears to be influenced at least in part by genetics, according to new study findings.
Researchers at the University of Southern California-Los Angeles and the University of California-Los Angeles included in their study 207 women who experienced HG during their singleton pregnancies, required intravenous hydration, and had at least 1 sister who had been pregnant. They compared the women's responses to a survey with those of 110 of their friends who had relatively nausea-free pregnancies.
The researchers found that the women with sisters who experienced HG were 17 times more likely to experience HG themselves, and about one-third of them (33%) had mothers who experienced HG compared with 7.7% of the controls. Data also suggest that maternal and paternal grandmothers, mothers, and daughters share a higher risk of severe morning sickness and HG, and the researchers note it is unlikely that this commonality can be explained solely by shared environmental and cross-generational factors.
The study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Zhang Y, Cantor RM, Macgibbon K, et al. Familial aggregation of hyperemesis gravidarum. Am J Obstet Gynecol. October 23, 2010. [Epub ahead of print.]
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More